Nanotechnology-Based Nucleic Acid Vaccines for Treatment of Ovarian Cancer

被引:0
作者
Simav Gildiz
Tamara Minko
机构
[1] Rutgers,Department of Pharmaceutics
[2] the State University of New Jersey,undefined
[3] Rutgers Cancer Institute of New Jersey,undefined
[4] Rutgers,undefined
[5] the State University of New Jersey,undefined
来源
Pharmaceutical Research | 2023年 / 40卷
关键词
cancer; mRNA; nanoparticles; ovarian; vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:123 / 144
页数:21
相关论文
共 971 条
[31]  
Siegel RL(2018)Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada BMC Cancer 18 1039-585
[32]  
Andrews L(2018)Familial risks of ovarian cancer by age at diagnosis, proband type and histology PLoS One 13 e0205000-1166
[33]  
Mutch DG(1993)Ovarian cancer. Survival and treatment differences by age Cancer 71 524-72
[34]  
Bell DA(2016)Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study BMJ Open 6 e010123-374
[35]  
Momenimovahed Z(2003)Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study Am J Epidemiol 158 629-1442
[36]  
Tiznobaik A(1995)A prospective study of reproductive factors and risk of epithelial ovarian cancer Cancer 76 284-359
[37]  
Taheri S(2006)Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study Cancer Causes Control 17 821-1083
[38]  
Salehiniya H(2017)Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer Br J Cancer 116 964-777
[39]  
Stewart C(1988)Reproductive factors and risk of ovarian cancer: a prospective study Int J Cancer 42 246-916
[40]  
Ralyea C(2001)Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study Gynecol Oncol 83 575-247